Vertex Pharmaceuticals Stock Forecast

Sell candidate since Jun 08, 2026

The Vertex Pharmaceuticals Incorporated stock price fell by -0.83% on the last day (Monday, 8th Jun 2026) from 389.40€ to 386.15€. During the last trading day the stock fluctuated 1.64% from a day low at 384.90€ to a day high of 391.20€. The price has fallen in 5 of the last 10 days but is still up by 2.29% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -19 shares and in total, 33 shares were bought and sold for approximately 12.74€ thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.19% during the next 3 months and, with a 90% probability hold a price between 322.70€ and 370.38€ at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

VX1.DE Signals & Forecast

The Vertex Pharmaceuticals Incorporated stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 375.99€ and 373.06€. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 05, 2026, and so far it has fallen -0.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock

Vertex Pharmaceuticals Incorporated finds support from accumulated volume at 380.45€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved 6.30€ between high and low, or 1.64%. For the last week the stock has had daily average volatility of 1.01%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VX1.DE) For The Upcoming Trading Day Of Tuesday 9th

For the upcoming trading day on Tuesday, 9th we expect Vertex Pharmaceuticals Incorporated to open at 387.42€, and during the day (based on 14 day Average True Range), to move between 382.36€ and 389.94€, which gives a possible trading interval of +/-7.58€ (+/-1.98%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 1.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 380.45€ (1.48%) than the resistance at 395.60€ (2.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vertex Pharmaceuticals Incorporated stock A Buy?

Vertex Pharmaceuticals Incorporated holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.149 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 9, 2026 - 387.42€ ( 0.328%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk